Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2460 of 5804
-
Nurses take the lead: new program gets cancer patients moving
Symptom relief Recruiting nowBackground: Physical activity has demonstrated benefits in alleviating side effects and improving well-being in people with cancer. However, activity levels remain low during systemic treatment. Nurses are optimally positioned to lead interventions fostering an activity-friendly …
Sponsor: St.Gallen University of Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New experimental drug BMS-986500 enters first human trials for advanced cancers
Disease control Recruiting nowThe purpose of this study is to assess BMS-986500 as monotherapy in advanced solid tumors and as combination therapy in CDK4/6 inhibitor pre-treated advanced breast cancer.
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Gut health drink may ease stress and boost memory in older adults
Symptom relief Recruiting nowTo assess the effect of 3 months of daily consumption of a postbiotic (inactivated lactic acid bacteria) Humiome® Post LB on stress measured by the Depression Anxiety Stress Scale-21 (DASS-21) adjusted on baseline in study participants when compared to placebo
Phase: NA • Sponsor: dsm-firmenich Switzerland AG • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a probiotic help fight cancer? early trial launches
Disease control Recruiting nowThe goal of this study is determine the safety and tolerability of orally taken probiotic (R-5780) in patients currently on a PD-1 Pathway Checkpoint Inhibitor (checkpoint protein on immune cells called T cells) with Solid Tumors.
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 26, 2026 14:14 UTC
-
New online program aims to ease anxiety for prostate cancer patients and their families
Symptom relief Recruiting nowMen with prostate cancer and their family caregivers face many physical and emotional challenges from the cancer itself and its treatment(s), which often lead to high anxiety. The pandemic has highlighted the importance of protecting our physical and mental health, and the comple…
Phase: NA • Sponsor: St. Mary's Research Center, Canada • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Gut bugs on board: probiotic drops may beat Traveler's tummy troubles
Disease control Recruiting nowInternational travel disrupts gut health through dietary changes, microbial exposure, and stress, often causing gastrointestinal symptoms like traveler's diarrhea and sleep disturbances. These shifts may increase antibiotic resistance risks. Probiotics may help stabilize gut micr…
Phase: PHASE2 • Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated Jun 26, 2026 18:30 UTC
-
Can a simple blood test predict dangerous side effects in breast cancer treatment?
Knowledge-focused Recruiting nowthe anti-Human Epidermal Growth Factor Receptor 2 (HER2) Trastuzumab-Deruxtecan (T-DXd) has shown impressive clinical activity in pretreated patients with metastatic breast cancer (MBC) but is also associated with a non-negligible rate of adverse events that may lead to treatment…
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New program aims to boost development in babies born with defects
Symptom relief Recruiting nowInfants born with congenital defects may require major surgery in the neonatal period. These infants are at risk for neurodevelopmental impairments. Additionally, their parents are at higher risk for adverse mental health outcomes. Early relationships are essential to healthy gr…
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New allergy shot shows promise in early trial
Symptom relief CompletedTo evaluate TQC2938 injection in all patients receiving background treatment with azelastine fluticasone nasal spray. The efficacy, safety and immunogenicity of the injection in patients with seasonal allergic rhinitis compared with placebo are expected to include 136 patients.
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Eat by your clock: new study targets belly fat
Disease control ENROLLING_BY_INVITATIONTime-restricted eating (TRE) has gained attention as a promising dietary strategy for enhancing body composition and metabolic health. This innovative eating pattern involves confining daily food intake to a specific window, typically spanning 6-10 hours. Given the lack of consen…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Hunting for hidden antibodies in brain inflammation
Knowledge-focused Recruiting nowAutoimmune encephalitis is a debilitating neurological disorder that usually appears as a rapidly progressive form of brain dysfunction, typically developing in less than six weeks, caused by inflammation in the brain. These conditions show a wide range of clinical and immunologi…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Can video games help Huntington's patients move and think better?
Symptom relief Recruiting nowHuntington's disease (HD) is a rare, hereditary neurodegenerative disorder. It generally manifests itself between the ages of 40 and 50, and results in motor impairment (choreic movements, balance disorders, gait disorders, etc.), cognitive impairment (executive functions, attent…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Sleep apnea device put to the test in heavier, more severe patients
Disease control Recruiting nowThe purpose of this observational clinical study is to provide evaluation of long-term safety and effectiveness in a newly expanded patient population including patients with a higher AHI and a higher BMI.
Sponsor: Inspire Medical Systems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Second chance: repeat islet transplants tested for type 1 diabetes
Disease control Recruiting nowIslet transplantation and pancreas transplantation are established therapeutic options for selected individuals with type 1 diabetes experiencing severe glycemic instability and recurrent hypoglycemia. Although these approaches significantly improve glycemic management and qualit…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Groundbreaking study could unlock early detection of vision issues in infants
Knowledge-focused ENROLLING_BY_INVITATIONCerebral visual impairment (CVI) is one of the leading causes of pediatric visual impairment and negatively impacts the development of motor, language, and cognitive skills. This study proposes to (1) establish a novel and easy to use CVI screening algorithm for infants and (2) d…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Cord blood infusions aim to slow Alzheimer's decline
Disease control Recruiting nowThis study is a single-center, prospective, double-blind, randomized controlled clinical trial (RCT). Employing a parallel-group design, the trial plans to enroll 30 clinically diagnosed AD patients, who will be randomly assigned via a computerized randomization tool into three …
Phase: EARLY_PHASE1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a Two-Drug HIV pill work for transgender women?
Disease control Recruiting nowThis single-arm, open label study is aimed to assess efficacy and safety of dolutegravir plus lamivudine as a switch strategy among TGW with HIV receiving suppresive antiretroviral therapy.
Phase: PHASE4 • Sponsor: UBATEC • Aim: Disease control
Last updated Jun 26, 2026 16:22 UTC
-
Personalized Omega-3s: a genetic key to heart health?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether omega-3 fatty acid supplementation can reduce inflammation-related biomarkers and improve cardiovascular health in healthy adult volunteers with different genetic backgrounds. The main questions it aims to answer are: Does the r…
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Childhood radiation linked to thyroid cancer? new study aims to find out
Knowledge-focused Recruiting nowThis study aims to define the optimal surveillance strategy for children exposed to radiotherapy by assessing the incidence, risk factors, and timing of thyroid nodules and differentiated thyroid cancer. It also investigates the genetic features of thyroid tumors in this populati…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Could a common arthritis drug ease knee osteoarthritis pain?
Symptom relief Recruiting nowBackground: Osteoarthritis (OA) is a leading cause of disability worldwide, with limited treatment options and many patients suffering from chronic pain. Modern imaging has revealed that OA involves complex changes in cartilage, subchondral bone, and synovium. Pain in OA is ofte…
Phase: PHASE2 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Symptom relief
Last updated Jun 26, 2026 16:29 UTC